:

Yeon-Koo Kang1

  • 1Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, 222 Banpo-daero, Seocho-gu, 06591 Republic of Korea.

概括

纤维细胞激活蛋白 (FAP) 向的放射性体疗法显示出有希望的结果,但需要进一步的研究. 结构性修改改善了瘤的保留,但针对FAP向癌症治疗的临床结果仍然没有确定性.